Back
ESC2025 Premium Access

Integrated efficacy and safety analysis of mavacamten monotherapy in patients with obstructive hypertrophic cardiomyopathy

Session: Precision medicine in hypertrophic cardiomyopathy
Topic: Hypertrophic Cardiomyopathy
Speaker: Professor I. Olivotto (Florence, IT)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Professor Iacopo Olivotto

University of Florence, Florence (Italy)
43 presentations
23 followers

3 more presentations in this session

State-of-the-art lecture on precision medicine in hypertrophic cardiomyopathy

Speaker: Doctor C. Ho (Boston, US)

Access
Slides
Video
Like
Thumbnail

Improved prognosis in hypertrophic cardiomyopathy over two decades - data from the Swedish national patient register

Speaker: Doctor J. Silverdal (Gothenburg, SE)

Access
Abstract
Slides
Video
Like
Thumbnail

Cardiovascular magnetic resonance-derived metrics as diagnostic markers for left ventricular outflow tract obstruction in hypertrophic cardiomyopathy

Speaker: Mr G. Alexandridis (Rotterdam, NL)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Precision medicine in hypertrophic cardiomyopathy

Speakers: Professor I. Olivotto, Doctor C. Ho, Doctor J. Silverdal, Mr G. Alexandridis
Access
Video
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources